Japanese Aerospace & Defense Stock News

As global markets grapple with energy price volatility and geopolitical tensions, Asian equities have been influenced by these broader economic pressures, prompting investors to reassess valuations across the region. In this environment, identifying stocks trading below their estimated intrinsic value can provide opportunities for investors seeking potential growth amidst uncertainty.

In the first quarter of 2026, Hamamatsu Photonics K.K. completed a board-approved buyback of 7,662,800 shares for ¥13,010.92 million, while Sakura Finetek and Hamamatsu announced an alliance to create a seamless workflow from tissue preparation to digital pathology imaging. Together, these moves highlight Hamamatsu’s focus on integrating its imaging technology into clinical diagnostics workflows while actively returning capital to shareholders through repurchases. We’ll now examine how...

Niterra (TSE:5334) has just completed a share buyback announced in October 2025, repurchasing 2,196,300 shares for ¥14,998.88 million. The company also raised earnings and dividend guidance for the fiscal year ending March 31, 2026. See our latest analysis for Niterra. Even after the latest 3.9% 1 day share price return to ¥7,511, Niterra’s 7.8% year to date share price return contrasts with a much stronger 1 year total shareholder return of 73.5%, hinting that momentum has cooled somewhat...

On March 24, 2026, Oriental Land Co., Ltd. approved the establishment of wholly owned subsidiary ORIENTAL LAND CRUISE CO., LTD. to manage and operate Japan-based Disney cruise services, with operations planned to begin in Japanese fiscal year 2028. This move extends Oriental Land’s business beyond Tokyo Disney Resort®, aligning with its 2035 Long-term Management Strategy to build a more diversified leisure portfolio centered on cruise operations. With the new cruise subsidiary set to run...

Calliditas Therapeutics AB, an Asahi Kasei company, has recently announced that new Phase 3 NefIgArd study data in primary immunoglobulin A nephropathy (IgAN) will be presented at the 2026 World Congress of Nephrology in Yokohama, Japan, including secondary, biomarker, and mechanistic analyses of its gut-targeted therapy Nefecon. This extensive dataset, spanning seven scientific posters and a dedicated symposium on the evolving IgAN treatment paradigm, underscores Asahi Kasei’s growing...

Investors may be wondering if Sumitomo at ¥6,182 is still priced fairly after such a strong run, or if the current share price is getting ahead of itself. The stock has returned 6.0% over the last 7 days, a 6.4% decline over 30 days, 11.0% year to date and 88.1% over the last year, along with a very large 3 year gain and 386.0% over 5 years that naturally raises questions about value. Recent coverage has focused on Sumitomo's position in the capital goods sector and how investors are...

Morinaga Milk Industry has completed its previously announced share repurchase program, buying back 2,865,300 shares, or 3.47% of its stock, for ¥9,999.57 million by March 25, 2026. The closure of this buyback, which steadily reduced the share count over several months, highlights the company’s current focus on capital returns to shareholders. We will now examine how the completion of this sizeable share repurchase program shapes Morinaga Milk Industry’s broader investment narrative. The...

ITOCHU (TSE:8001) has moved to expand in e-waste recycling, teaming up with ERI to co-own ERI Japan, a 50-50 venture that brings ERI’s IT asset disposition services into the Japanese market. See our latest analysis for ITOCHU. At a share price of ¥2,070.0, ITOCHU’s 1 day share price return of 4.84% contrasts with a 30 day share price decline of 7.20%. A 1 year total shareholder return of 54.43% and 5 year total shareholder return of 231.72% point to strong longer term compounding despite...

Why Meiji Holdings Is Back in Focus After Guidance Cut Meiji Holdings (TSE:2269) has drawn fresh attention after lowering full year earnings guidance, citing impairment losses tied to its China business and costs from structural reforms, alongside higher projected ordinary profit. See our latest analysis for Meiji Holdings. After the guidance cut and impairment related to its China business, Meiji Holdings' recent 1 day share price return of 1.66% contrasts with a 90 day share price return of...

Furukawa Electric (TSE:5801) is back in focus after the company announced plans to invest about ¥55 billion to scale production of cooling modules and heat sinks for data centers serving generative AI demand. See our latest analysis for Furukawa Electric. The latest AI related capex news comes on top of powerful recent momentum, with a 90 day share price return of 224.58% and a year to date share price return of 208.25%. The 1 year total shareholder return is also very large at over 5x. If...

Dentsu Group recently strengthened its Asia-Pacific leadership by appointing media veteran Sumit Kohli as head of investment for the region, tasking him with sharpening disciplined, outcome-focused media spending across digital and offline channels. This hire signals Dentsu’s push to tighten accountability and performance metrics in media buying, aligning investment decisions more closely with client priorities amid rising scrutiny over every rupee spent. We’ll now examine how Kohli’s focus...

Japan Hotel REIT Investment (TSE:8985) has drawn fresh attention after arranging new loans totaling ¥15.0b to refinance upcoming maturities, and reporting February 2026 revenue of ¥6,099m and year-to-date revenue of ¥11,966m. See our latest analysis for Japan Hotel REIT Investment. At a share price of ¥76,600, Japan Hotel REIT Investment has seen a 1 day share price return of 2.54%, while the 1 year total shareholder return is 13.18%. This suggests longer term holders have fared better than...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Rorze (TSE:6323) is back in focus after revising its fiscal 2026 earnings guidance, as an extraordinary loss tied to a jury verdict and litigation provision reshapes expected profit attributable to shareholders. See our latest analysis for Rorze. The guidance cut linked to litigation arrives after a choppy period for the shares, with a 30 day share price return of a 13.88% decline, a 90 day share price return of 21.40%, and a 1 year total shareholder return of 92.73%. This suggests that...

Recent share price moves in Okuma (TSE:6103) have drawn attention, with a 6.6% gain over the past day contrasting with a month decline of about 19%, prompting fresh questions about valuation and earnings power. See our latest analysis for Okuma. Zooming out, Okuma’s share price return has mixed momentum. There has been a 19.3% decline over the past month, contrasting with a 3.0% 90 day gain and a 2.8% year to date rise, while the 1 year total shareholder return stands at 16.4%. If you are...

ORIX JREIT (TSE:8954) recently announced new debt financing totaling ¥6,897 million, including a sustainability linked loan, and expanded its unsecured commitment line to ¥10,000 million. These moves directly affect its funding profile. See our latest analysis for ORIX JREIT. At a share price of ¥98,800, ORIX JREIT has a 1 year total shareholder return of 15.75%, while its year to date share price return of 7.49% and 90 day share price return of 7.06% suggest momentum has cooled in the short...

Nidec (TSE:6594) is under fresh scrutiny after a shareholder asked the company to pursue legal action against current and former directors over alleged improper accounting and governance issues. See our latest analysis for Nidec. The renewed governance concerns are affecting a stock that has already been under pressure. The 1-year total shareholder return shows a 13.72% decline and the 5-year total shareholder return shows a 68.43% decline. The latest 1-day share price return of 7.48% follows...

The Hennessy Japan Small Cap Fund has fully exited Musashino Bank (TSE:8336), selling all 376,800 shares and reducing the position’s weight in its portfolio by 2.75%, according to recent N-PORT filings. See our latest analysis for Musashino Bank. Despite the fund’s full exit, Musashino Bank’s share price has been firm, with a 1 day share price return of 7.54% and a 90 day share price return of 38.27%. The 1 year total shareholder return of 118.27% and 5 year total shareholder return of about...

Kokusai Electric Corporation (TSE:6525) was added to the S&P Japan Mid Cap 100 index on 25 March 2026, reflecting its inclusion among mid-sized Japanese equities tracked by this benchmark. This index inclusion could draw additional attention from institutional and index-tracking investors, potentially affecting trading activity and how the company is assessed alongside its domestic peers. We will now examine how Kokusai Electric’s addition to the S&P Japan Mid Cap 100 may influence its...

What Sega Sammy’s Completed Buyback and Planned Share Cancellation Mean for Investors Sega Sammy Holdings (TSE:6460) has wrapped up its share repurchase program, buying 7,684,100 shares for ¥19,999.86 million, and now plans a board meeting to decide when these treasury shares will be canceled. See our latest analysis for Sega Sammy Holdings. The buyback and planned share cancellation come at a time when the share price has risen 3.14% over the past day and 2.10% over 90 days. Over one year,...

Komatsu stock reaction and key recent performance Komatsu (TSE:6301) recently caught investor attention after a positive 1 day move of about 8.1%, standing out against a month return of roughly 14.3% decline and a past 3 months gain of 30.0%. See our latest analysis for Komatsu. Set against a volatile few months, Komatsu’s recent 1 day share price return of 8.1% at ¥6,502 comes after a 30 day share price return decline of 14.4% and a 1 year total shareholder return of 53.1%, suggesting...

Why Advantest’s recent returns have investors paying attention Advantest (TSE:6857) has caught investor interest after a sharp 1 year total return of 250%, along with a 13% pullback over the past month and a 15% gain over the past 3 months. See our latest analysis for Advantest. The recent 1 day share price return of 10.7% comes after a 30 day share price return of a 12.77% decline and a very large 5 year total shareholder return. Momentum has cooled slightly but remains tied to a long run of...

KDDI (TSE:9433) has just posted its Q3 2026 numbers, with revenue of about ¥1.5 trillion and basic EPS of ¥44.08, while trailing twelve month revenue sits at roughly ¥6.1 trillion and EPS at ¥182.85 as profit margins improved over the past year. The company has seen quarterly revenue hold around the ¥1.5 trillion mark between Q3 2025 and Q3 2026, with EPS moving in a range from ¥37.46 to ¥54.18 as net income tracked between ¥149.15 billion and ¥206.60 billion over the same stretch. For...

Takeda Pharmaceutical (TSE:4502) announced that CEO Christophe Weber plans to retire in June 2026. Several members of Takeda’s Board of Directors are also set to step down as part of a broader leadership refresh. The company highlighted that this transition is being planned ahead of time while it continues to advance its drug pipeline. As one of Japan’s largest pharmaceutical groups, Takeda is a key player in prescription medicines and research driven drug development. The planned...